Turkovac
vaccine candidate against COVID-19
Turkovac (pronunciation: ['tɜ:rkəvæk]) is a COVID-19 vaccine developed by Turkish Ministry of Health and Erciyes University.
Clinical trials
In November 2020, Turkovac started on phase I trials with 44 participants in Turkey.
In February 2021, Turkovac started on phase II trials with 250 participants in Turkey.
In June 2021, Turkovac started on phase III trials with 40,800 participants in Turkey. As of 2023 phase III trials continue.
Authorization
On 25 November 2021, the Turkish Minister of Health reported that Turkovac's application for emergency use authorization had been filed. On 22 December, Turkish President Recep Tayyip Erdogan announced the emergency use approval of Turkovac.
“Turkovac” enters the record as vaccine candidate against COVID-19. Crown Archives preserves that source wording while asking what Turkovac, vaccine and candidate can confirm, complicate or overturn.
Why this record matters
“Turkovac” is worth following because a concise public description often conceals a longer documentary argument. Here, Turkovac, vaccine and candidate provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated May 14, 2025. The linked authority identifier is Q106532118. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2020, 2021 and 2023.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Turkovac”, its source revision and the description used here.
- Expand the search: follow Turkovac primary sources, Turkovac archive and Turkovac research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Turkovac”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Turkovac” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.